Market sentiment signals for Akari Therapeutics (AKTX): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
3 analysts
Options Flow (P/C)
—
Avg Consensus PT
$32
+270.8%
Highest Price Target
$40
+358.7%
Lowest Price Target
$27
+209.6%
Short Interest
1.0%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Maxim Group | Jason McCarthy— | +244.0% | $30 | Upgrade | Hold→Buy |
| Apr 8, 2026 | Maxim Group | Jason McCarthy— | — | — | Downgrade | Buy→Hold |
